{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:17:25Z","timestamp":1768457845271,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.2515\/therapie:2005061","type":"journal-article","created":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T03:55:53Z","timestamp":1173758153000},"page":"419-422","source":"Crossref","is-referenced-by-count":46,"title":["Trimetazidine Induces Parkinsonism, Gait Disorders and Tremor"],"prefix":"10.1016","volume":"60","author":[{"given":"Jos\u00e9-F\u00e9lix Mart\u00ed","family":"Mass\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itxaso","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-Jos\u00e9","family":"Poza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo L\u00f3pez","family":"de Munain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.2515\/therapie:2005061_bb1300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003495-199958010-00016","article-title":"Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions","volume":"58","author":"McClellan","year":"1999","journal-title":"Drugs"},{"issue":"60","key":"10.2515\/therapie:2005061_bb1305","first-page":"101","article-title":"Trimetazidine: a second look. Still no efficacy in visual disorders","volume":"11","year":"2002","journal-title":"Prescrire Int"},{"issue":"1","key":"10.2515\/therapie:2005061_bb1310","first-page":"43","article-title":"Int\u00e9r\u00eat de vastarel 20mg (trim\u00e9tazidine) dans le traitement des vertiges","volume":"116","author":"Bouccara","year":"1999","journal-title":"Ann Otolaryngol Chir Cervicofac"},{"issue":"Suppl. 1","key":"10.2515\/therapie:2005061_bb1315","first-page":"S25","article-title":"Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies","volume":"12","author":"Szwed","year":"2001","journal-title":"Coron Artery Dis"},{"key":"10.2515\/therapie:2005061_bb1320","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.55.9.1358","article-title":"Parkinson\u2019s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group Italian Longitudinal Study on Aging","volume":"55","author":"Baldereschi","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.2515\/therapie:2005061_bb1325","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/mds.870130313","article-title":"Cinnarizine-induced parkinsonism: ten years later","volume":"13","author":"Marti-Masso","year":"1998","journal-title":"Mov Disord"},{"issue":"3","key":"10.2515\/therapie:2005061_bb1330","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/106002809202600320","article-title":"Lopez de Munain A, Lopez de Dicastillo G. Ataxia following gastric bleeding due to omeprazole-benzodiazepine interaction","volume":"26","author":"Marti-Masso","year":"1992","journal-title":"Ann Pharmacother"},{"issue":"15","key":"10.2515\/therapie:2005061_bb1335","first-page":"614","article-title":"Posible parkinsonismo causado por cinaricina","volume":"85","author":"Marti-Masso","year":"1985","journal-title":"Med Clin (Barc)"},{"issue":"2","key":"10.2515\/therapie:2005061_bb1340","first-page":"55","article-title":"Cinaricina y enfermedad de Parkinson. Estudio doble ciego controlado con placebo","volume":"1","author":"Marti-Masso","year":"1986","journal-title":"Neurologia"},{"issue":"6","key":"10.2515\/therapie:2005061_bb1345","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/jnnp.50.6.804","article-title":"Aggravation of Parkinson\u2019s disease by cinnarizine","volume":"50","author":"Marti-Masso","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716303213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716303213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T02:56:40Z","timestamp":1554260200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716303213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0040595716303213"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2005061","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}